Vanguard Group Inc Checkpoint Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
$1.53 - $3.25 $63,478 - $134,839
41,489 Added 1.39%
3,017,783 $5.34 Million
Q4 2021

Feb 14, 2022
BUY
$2.68 - $4.46 $666,483 - $1.11 Million
248,688 Added 9.12%
2,976,294 $9.26 Million
Q3 2021

Nov 12, 2021
BUY
$2.5 - $3.53 $359,057 - $506,989
143,623 Added 5.56%
2,727,606 $9 Million
Q2 2021

Aug 13, 2021
BUY
$2.36 - $3.2 $6.1 Million - $8.27 Million
2,583,983 New
2,583,983 $7.62 Million

Others Institutions Holding CKPT

# of Institutions
3
Shares Held
1.91M
Call Options Held
0
Put Options Held
0
View Full List

About Checkpoint Therapeutics, Inc.

CKPT Quotes by TradingView
  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $234M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email